DEP Updates from AGM Presentation November 2020.
- DEP docetaxel - Was 37 now 40 (+3) - Not sure what trial figures are said to be for phase 2.
- DEP cabazitaxel - Was 17 with phase 2 first stage trail participant aim of 30 - Now 35 (+18) - appears over and above aim
- DEP Irinotecan - Phase 2 was 27 now 40 +13 - Not sure on population target
Appears to me that recruitment has gone well and at least one trial is fully recruited, anyone else have views on enrollment numbers please?
- Forums
- ASX - By Stock
- SPL
- DEP Enrollment Update
SPL
starpharma holdings limited
Add to My Watchlist
2.17%
!
9.0¢

DEP Enrollment Update
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.0¢ |
Change
-0.002(2.17%) |
Mkt cap ! $37.64M |
Open | High | Low | Value | Volume |
9.1¢ | 9.1¢ | 9.0¢ | $15.52K | 171.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 131472 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.1¢ | 99310 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 131472 | 0.090 |
2 | 150000 | 0.089 |
1 | 250000 | 0.088 |
2 | 124999 | 0.087 |
2 | 29702 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.091 | 99310 | 1 |
0.092 | 43400 | 2 |
0.093 | 110752 | 2 |
0.094 | 50000 | 1 |
0.095 | 70642 | 5 |
Last trade - 14.48pm 04/07/2025 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online